The global Safety Lancets market size is predicted to grow from US$ 636 million in 2025 to US$ 892 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Safety lancets are single-use devices for capillary blood sampling dedicated to healthcare professionals. They are an integral component to the sharps-injury prevention programs in hospitals, clinics, laboratories, doctor鈥檚 offices and wherever both patients and professionals need to feel safe. By using safety lancets, needle-stick injuries and infections can be eliminated.
Drivers of the Safety Lancets 麻豆原创:
Increasing Prevalence of Diabetes: The growing incidence of diabetes globally has led to a rise in the demand for frequent blood glucose monitoring. Safety lancets are widely used in diabetes management, driving the market.
Focus on Safety and Infection Control: Concerns over needle-stick injuries and blood borne infections are pushing healthcare providers to adopt safer devices like safety lancets, which minimize these risks through single-use mechanisms.
Rising 麻豆原创 Healthcare Adoption: The trend toward home-based care, especially for patients with chronic conditions, has increased the demand for user-friendly medical devices, including safety lancets.
Technological Innovation: Advancements in lancet design, such as automatic, pain-minimizing, and ergonomically improved lancets, are enhancing patient experience and encouraging wider adoption.
Government Regulations and Support: Many governments have implemented strict regulations that favor the use of safety-engineered devices to improve healthcare worker safety, fostering the growth of the safety lancets market.
Challenges of the Safety Lancets 麻豆原创:
Higher Costs: Safety lancets tend to be more expensive than traditional lancets, which can limit adoption, especially in low-resource healthcare settings.
Lack of Awareness in Developing Regions: Limited awareness of safety lancets, along with insufficient healthcare infrastructure in developing countries, hampers market penetration.
Environmental Impact: The single-use nature of safety lancets contributes to medical waste, raising concerns about environmental sustainability and prompting the search for more eco-friendly solutions.
Competition from Alternative Technologies: Emerging blood sampling technologies, such as continuous glucose monitoring (CGM) systems that reduce the need for finger pricking, may present competition to safety lancets.
Limited Reimbursement Policies: In some regions, the lack of favorable reimbursement policies for diagnostic devices like safety lancets can act as a barrier to widespread adoption.
Global key players of safety lancets include HTL-STREFA, BD, Roche, etc. The top three players hold a share about 33%. Americas is the largest market, has a share about 42%, followed by Europe and Asia-Pacific, with share 31% and 23%, separately.
The 鈥淪afety Lancets Industry Forecast鈥� looks at past sales and reviews total world Safety Lancets sales in 2024, providing a comprehensive analysis by region and market sector of projected Safety Lancets sales for 2025 through 2031. With Safety Lancets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Safety Lancets industry.
This Insight Report provides a comprehensive analysis of the global Safety Lancets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Safety Lancets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Safety Lancets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Safety Lancets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Safety Lancets.
This report presents a comprehensive overview, market shares, and growth opportunities of Safety Lancets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Safety Lancets with Needle
Safety Lancets with Blade
Segmentation by Application:
Hospital & Clinics
麻豆原创
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
BD
Ascensia
Lifescan
B. Braun
Terumo
Nipro
Cardinal Health
ARKRAY
ICU Medical
Owen Mumford
HemoCue
Greiner Bio One
HTL-STREFA
Sarstedt
UltiMed
Tianjin Huahong
Guangzhou iCare Medical
Shandong Lianfa
SteriLance Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Safety Lancets market?
What factors are driving Safety Lancets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Safety Lancets market opportunities vary by end market size?
How does Safety Lancets break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Safety Lancets Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Safety Lancets by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Safety Lancets by Country/Region, 2020, 2024 & 2031
2.2 Safety Lancets Segment by Type
2.2.1 Safety Lancets with Needle
2.2.2 Safety Lancets with Blade
2.3 Safety Lancets Sales by Type
2.3.1 Global Safety Lancets Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Safety Lancets Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Safety Lancets Sale Price by Type (2020-2025)
2.4 Safety Lancets Segment by Application
2.4.1 Hospital & Clinics
2.4.2 麻豆原创
2.4.3 Other
2.5 Safety Lancets Sales by Application
2.5.1 Global Safety Lancets Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Safety Lancets Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Safety Lancets Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Safety Lancets Breakdown Data by Company
3.1.1 Global Safety Lancets Annual Sales by Company (2020-2025)
3.1.2 Global Safety Lancets Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Safety Lancets Annual Revenue by Company (2020-2025)
3.2.1 Global Safety Lancets Revenue by Company (2020-2025)
3.2.2 Global Safety Lancets Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Safety Lancets Sale Price by Company
3.4 Key Manufacturers Safety Lancets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Safety Lancets Product Location Distribution
3.4.2 Players Safety Lancets Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Safety Lancets by Geographic Region
4.1 World Historic Safety Lancets 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Safety Lancets Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Safety Lancets Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Safety Lancets 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Safety Lancets Annual Sales by Country/Region (2020-2025)
4.2.2 Global Safety Lancets Annual Revenue by Country/Region (2020-2025)
4.3 Americas Safety Lancets Sales Growth
4.4 APAC Safety Lancets Sales Growth
4.5 Europe Safety Lancets Sales Growth
4.6 Middle East & Africa Safety Lancets Sales Growth
5 Americas
5.1 Americas Safety Lancets Sales by Country
5.1.1 Americas Safety Lancets Sales by Country (2020-2025)
5.1.2 Americas Safety Lancets Revenue by Country (2020-2025)
5.2 Americas Safety Lancets Sales by Type (2020-2025)
5.3 Americas Safety Lancets Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Safety Lancets Sales by Region
6.1.1 APAC Safety Lancets Sales by Region (2020-2025)
6.1.2 APAC Safety Lancets Revenue by Region (2020-2025)
6.2 APAC Safety Lancets Sales by Type (2020-2025)
6.3 APAC Safety Lancets Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Safety Lancets by Country
7.1.1 Europe Safety Lancets Sales by Country (2020-2025)
7.1.2 Europe Safety Lancets Revenue by Country (2020-2025)
7.2 Europe Safety Lancets Sales by Type (2020-2025)
7.3 Europe Safety Lancets Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Safety Lancets by Country
8.1.1 Middle East & Africa Safety Lancets Sales by Country (2020-2025)
8.1.2 Middle East & Africa Safety Lancets Revenue by Country (2020-2025)
8.2 Middle East & Africa Safety Lancets Sales by Type (2020-2025)
8.3 Middle East & Africa Safety Lancets Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Safety Lancets
10.3 Manufacturing Process Analysis of Safety Lancets
10.4 Industry Chain Structure of Safety Lancets
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Safety Lancets Distributors
11.3 Safety Lancets Customer
12 World Forecast Review for Safety Lancets by Geographic Region
12.1 Global Safety Lancets 麻豆原创 Size Forecast by Region
12.1.1 Global Safety Lancets Forecast by Region (2026-2031)
12.1.2 Global Safety Lancets Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Safety Lancets Forecast by Type (2026-2031)
12.7 Global Safety Lancets Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Safety Lancets Product Portfolios and Specifications
13.1.3 Roche Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 BD
13.2.1 BD Company Information
13.2.2 BD Safety Lancets Product Portfolios and Specifications
13.2.3 BD Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 BD Main Business Overview
13.2.5 BD Latest Developments
13.3 Ascensia
13.3.1 Ascensia Company Information
13.3.2 Ascensia Safety Lancets Product Portfolios and Specifications
13.3.3 Ascensia Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Ascensia Main Business Overview
13.3.5 Ascensia Latest Developments
13.4 Lifescan
13.4.1 Lifescan Company Information
13.4.2 Lifescan Safety Lancets Product Portfolios and Specifications
13.4.3 Lifescan Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lifescan Main Business Overview
13.4.5 Lifescan Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Safety Lancets Product Portfolios and Specifications
13.5.3 B. Braun Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Safety Lancets Product Portfolios and Specifications
13.6.3 Terumo Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Nipro
13.7.1 Nipro Company Information
13.7.2 Nipro Safety Lancets Product Portfolios and Specifications
13.7.3 Nipro Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Nipro Main Business Overview
13.7.5 Nipro Latest Developments
13.8 Cardinal Health
13.8.1 Cardinal Health Company Information
13.8.2 Cardinal Health Safety Lancets Product Portfolios and Specifications
13.8.3 Cardinal Health Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Cardinal Health Main Business Overview
13.8.5 Cardinal Health Latest Developments
13.9 ARKRAY
13.9.1 ARKRAY Company Information
13.9.2 ARKRAY Safety Lancets Product Portfolios and Specifications
13.9.3 ARKRAY Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 ARKRAY Main Business Overview
13.9.5 ARKRAY Latest Developments
13.10 ICU Medical
13.10.1 ICU Medical Company Information
13.10.2 ICU Medical Safety Lancets Product Portfolios and Specifications
13.10.3 ICU Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 ICU Medical Main Business Overview
13.10.5 ICU Medical Latest Developments
13.11 Owen Mumford
13.11.1 Owen Mumford Company Information
13.11.2 Owen Mumford Safety Lancets Product Portfolios and Specifications
13.11.3 Owen Mumford Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Owen Mumford Main Business Overview
13.11.5 Owen Mumford Latest Developments
13.12 HemoCue
13.12.1 HemoCue Company Information
13.12.2 HemoCue Safety Lancets Product Portfolios and Specifications
13.12.3 HemoCue Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 HemoCue Main Business Overview
13.12.5 HemoCue Latest Developments
13.13 Greiner Bio One
13.13.1 Greiner Bio One Company Information
13.13.2 Greiner Bio One Safety Lancets Product Portfolios and Specifications
13.13.3 Greiner Bio One Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Greiner Bio One Main Business Overview
13.13.5 Greiner Bio One Latest Developments
13.14 HTL-STREFA
13.14.1 HTL-STREFA Company Information
13.14.2 HTL-STREFA Safety Lancets Product Portfolios and Specifications
13.14.3 HTL-STREFA Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 HTL-STREFA Main Business Overview
13.14.5 HTL-STREFA Latest Developments
13.15 Sarstedt
13.15.1 Sarstedt Company Information
13.15.2 Sarstedt Safety Lancets Product Portfolios and Specifications
13.15.3 Sarstedt Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sarstedt Main Business Overview
13.15.5 Sarstedt Latest Developments
13.16 UltiMed
13.16.1 UltiMed Company Information
13.16.2 UltiMed Safety Lancets Product Portfolios and Specifications
13.16.3 UltiMed Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 UltiMed Main Business Overview
13.16.5 UltiMed Latest Developments
13.17 Tianjin Huahong
13.17.1 Tianjin Huahong Company Information
13.17.2 Tianjin Huahong Safety Lancets Product Portfolios and Specifications
13.17.3 Tianjin Huahong Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Tianjin Huahong Main Business Overview
13.17.5 Tianjin Huahong Latest Developments
13.18 Guangzhou iCare Medical
13.18.1 Guangzhou iCare Medical Company Information
13.18.2 Guangzhou iCare Medical Safety Lancets Product Portfolios and Specifications
13.18.3 Guangzhou iCare Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Guangzhou iCare Medical Main Business Overview
13.18.5 Guangzhou iCare Medical Latest Developments
13.19 Shandong Lianfa
13.19.1 Shandong Lianfa Company Information
13.19.2 Shandong Lianfa Safety Lancets Product Portfolios and Specifications
13.19.3 Shandong Lianfa Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Shandong Lianfa Main Business Overview
13.19.5 Shandong Lianfa Latest Developments
13.20 SteriLance Medical
13.20.1 SteriLance Medical Company Information
13.20.2 SteriLance Medical Safety Lancets Product Portfolios and Specifications
13.20.3 SteriLance Medical Safety Lancets Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 SteriLance Medical Main Business Overview
13.20.5 SteriLance Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
